Standard anthracycline-based vs. docetaxel-capecitabine in early breast cancer: Results from the chemotherapy randomization (R-C) of EORTC 10041/ BIG 3-04 MINDACT phase III trial. This is an ASCO ...
The French Agency for Food, Environmental and Occupational Health & Safety (ANSES) has proposed classifying resorcinol as an endocrine disruptor under the European Classification, Labelling and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results